Bancorp of New Jersey (BKJ) Raised to B at TheStreet

Share on StockTwits

TheStreet upgraded shares of Bancorp of New Jersey (NYSEAMERICAN:BKJ) from a c+ rating to a b rating in a research report report published on Wednesday, TheStreetRatingsTable reports.

BKJ opened at $13.39 on Wednesday. Bancorp of New Jersey has a one year low of $12.49 and a one year high of $17.95.

Bancorp of New Jersey (NYSEAMERICAN:BKJ) last posted its earnings results on Thursday, March 14th. The financial services provider reported $0.16 EPS for the quarter. The firm had revenue of $6.78 million for the quarter.

Several large investors have recently modified their holdings of BKJ. Kore Private Wealth LLC purchased a new stake in shares of Bancorp of New Jersey in the first quarter valued at $49,000. Dimensional Fund Advisors LP lifted its position in shares of Bancorp of New Jersey by 20.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 42,846 shares of the financial services provider’s stock valued at $558,000 after acquiring an additional 7,352 shares in the last quarter. Finally, Vanguard Group Inc lifted its position in shares of Bancorp of New Jersey by 6.9% in the third quarter. Vanguard Group Inc now owns 45,917 shares of the financial services provider’s stock valued at $785,000 after acquiring an additional 2,964 shares in the last quarter.

Bancorp of New Jersey Company Profile

Bancorp Of New Jersey, Inc operates as a bank holding company of Bank of New Jersey that provides various banking products and services to individuals, businesses, non-profit organizations, and governmental units. The company offers various deposit products, including interest and noninterest checking, passbook savings, and money market accounts; and time deposits, such as certificates of deposit and individual retirement accounts.

Further Reading: Debt-To-Equity Ratio

Receive News & Ratings for Bancorp of New Jersey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bancorp of New Jersey and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Head-To-Head Analysis: Debenhams  versus ORIENTAL LD CO/ADR
Head-To-Head Analysis: Debenhams versus ORIENTAL LD CO/ADR
Comparing MEI Pharma  & Cambrex
Comparing MEI Pharma & Cambrex
Analyzing Denny’s  and Granite City Food & Brewery
Analyzing Denny’s and Granite City Food & Brewery
Westlake Chemical  Upgraded at ValuEngine
Westlake Chemical Upgraded at ValuEngine
Morgan Stanley Reiterates “$84.00” Price Target for Exxon Mobil
Morgan Stanley Reiterates “$84.00” Price Target for Exxon Mobil
Tenax Therapeutics  versus Its Rivals Critical Contrast
Tenax Therapeutics versus Its Rivals Critical Contrast


 
© 2006-2019 Zolmax.